Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...
Scientists from the Tokyo Medical and Dental University (TMDU) used photoelectrochemical measurement and X-ray photoelectron spectroscopy to clarify the source of titanium's biocompatibility when ...
Medical implants have transformed health care, offering innovative solutions with advanced materials and technologies. However, many biomedical devices face challenges like insufficient cell adhesion, ...
NASARIX achieves positive biological safety results Shares of Polyrizon Ltd. (NASDAQ:PLRZ) gained 10% on Friday after the ...
Biocompatibility evaluation must accompany any medical device that has contact with a patient during use and is a requirement before a device can be cleared for market. This is usually the last step ...
Biocompatibility testing is a necessary part of any medical device validation process. It is governed by FDA’s ISO 10993 guidance document, a seemingly rigid statement that provides a general matrix ...
Medical implants and biomedical devices often cause inflammatory responses due to poor biocompatibility. Apatite coatings offer a potential solution but limited cell adhesion is often a challenge. To ...